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Malignant melanoma possesses a unique metabolic pathway
for the conversion of L-dopa to melanin which is mediated
by the melanocyte-specific enzyme tyrosinase (Pawelek,
1976). Wick et al. (1977, 1978) showed that L-dopa and its
chemical analogues are selectively cytotoxic to melanoma
cells in vitro and exhibit significant antitumour activity
against murine melanoma in vivo. As for a mechanism of the
selective toxicity to melanoma cells, it has been postulated
that L-dopa analogues are oxidized by tyrosinase to o-
quinone forms that act as sulphydryl reagents, thus
inhibiting the activity of essential enzymes such as DNA
polymerase a (Graham et al., 1978; Wick, 1980). In an
attempt to obtain more effective agents, we have synthesized
4-S-cysteinylcatechol (4-S-CC) and related compounds as
new analogues of L-dopa (Ito et al., 1981). In this report, we
studied the killing effects of 4-S-CC and analogues on
human melanoma cells, and compared them with those of
L-dopa.
The five new compounds were synthesized at Fujita-
Gakuen Health University, Toyoake, Aichi, Japan, by one of
the authors (Dr S. Ito). Details of the chemical synthesis
have been reported elsewhere (Ito et al., 1981), and the
chemical structures of the synthetic compounds and L-dopa
are shown in Figure 1. 4-S-CC was a sulphur homologue of
L-dopa, in which only a sulphur atom was introduced into a
molecule of L-dopa. 3-S-Cysteinylcatechol (3-S-CC), 2-S-
cysteinylhydroquinone (2-S-CH), and 2-S-cysteinylresorcinol
(2-S-CR) were chemical isomers of 4-S-CC. 3-S-Cysteinyl-5-
methylcatechol (3-S-C-5-MC) was a methyl conjugate of 3-S-
CC in its C-5 position. L-dopa was purchased from Sigma
Chemical Co. (St Louis, MO). All the drug solutions were
freshly prepared in Ham's F-10 medium (GIBCO) just
before use at the beginning of each experiment.
The human melanoma cell line (HMV-II) used in this
study was derived from a malignant melanoma in the vaginal
wall of a woman (Kasuga et al., 1971), and has maintained
prominent melanin-producing activity up to the present. The
HMV-II cells were maintained in Ham's F-10 medium
supplemented with 20% foetal calf serum (Flow
Laboratories), penicillin (lOOUml-1) and streptomycin
(100 gml-1), and incubated in a humidified atmosphere of
95% air and 5% carbon dioxide at 37°C.
Cells (2 x105) were plated in 60mm plastic dishes (tissue
culture Petri dish; Falcon). After 48 h incubation, the
medium was replaced with fresh culture medium containing
the desired concentrations of each drug, and the cell cultures
were incubated for 1 h at 37°C. Duplicate cultures were set
up at each of the concentrations, and assays were performed
at least three times for each drug. After drug exposure the
medium was removed, and the cells were rinsed twice with
F-10 medium. The cells were trypsinized and counted with a
Model D Coulter Counter (Coulter Electronics, Inc.,
Hialeah, FL). The fresh medium containing an appropriate
number of cells and 0.33% soft agar was poured on the base
layer of 0.5% soft agar which had been plated previously in
60mm plastic dishes, and the cells were incubated for 21
days in a CO2 incubator at 37°C. A colony containing >50
cells was counted as a viable colony, and the surviving
fraction was calculated in reference to controls. The average
plating efficiency of control cells was 30.9% throughout the
experimental period. The mean lethal dose (Do) was
measured from the straight portion of the survival curve as
the dose required to reduce survival to 37%, and the
extrapolation number (n) was measured by extrapolation of
the straight portion of the survival curve to the ordinate.
The two parameters for each survival curve were determined
from least squares linear regression.
Dose-response survival curves of HMV-II melanoma cells
after one hour's treatment with each drug are shown in
Figure 2, and the Do and n values of each drug are
summarized in Table I. The Do value of L-dopa, examined
for the purpose of comparison, was 3.16mgml-1, and L-
dopa was demonstrated to be considerably weak in killing
melanoma cells. On the contrary, 4-S-cysteinylcatechol, a
sulphur homologue of L-dopa, had a Do value of
0.01mgml-1, and showed remarkably potent killing effects
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Figure 1 Chemical structures of the synthetic compounds and
L-dopa. R= -CH2CH(NH2)COOH.
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Figure 2 Effects of the drugs on the survival of HMV-II human
melanoma cells. The cells were exposed to the different
concentrations of each drug for 1 h at 370C. The cell survival was
estimated by the ability to form viable colonies, and the results
are expressed as a fraction of control cell survival. Values
represent mean of 3 to 5 determinations. All standard deviations
were less than 10%. 0, 4-S-CC; LI, 2-S-CH; A, 3-S-C-5-MC; A,
3-S-CC; *, 2-S-CR; 0, L-dopa.
Table I Killing effects of 4-S-CC and related analogs on HMV-II
human melanoma cells
Parameters'
Do ratio Significance
Drug Do (mgml-1) n (L-dopa/drug) (P value)b
4-S-CC 0.010 1.0 316.00 <0.01
2-S-CH 0.035 2.1 90.29 <0.01
3-S-C-5-MC 0.271 1.2 11.66 <0.01
3-S-CC 1.68 1.0 1.88 NSC
2-S-CR 6.02 1.0 0.52 NS
L-dopa 3.16 0.9 1.00
aEach Do and n value is an average from 3 to 5 separate
experiments; 'The significance was calculated between L-dopa and
other drugs by the Student's t test; CNS, not significant.
on melanoma cells compared with L-dopa. When the effects
of the two drugs were compared on the basis of the ratio of
the Do value, 4-S-CC was -316-fold more potent in killing
melanoma cells than L-dopa (P<0.01). 3-S-Cysteinylcatechol
had a Do value of 1.68mgml-1'; the killing activity of 3-S-
CC was comparable to L-dopa in potency. However, 3-S-
cysteinyl-5-methylcatechol, a methyl conjugate of 3-S-CC,
had a Do value of 0.271mgml-1, and was intermediate
among the drugs examined (Table I). The Do ratio of 3-S-C-
5-MC in reference to L-dopa was 11.66 (P<0.01). 2-S-
Cysteinylhydroquinone had a Do value of 0.035mgml-1 and
was remarkably potent in killing melanoma cells. The killing
activity of 2-S-CH was next to that of 4-S-CC in potency,
and the Do ratio in reference to L-dopa was 90 (P<0.01).
However, 2-S-cysteinylresorcinol had a Do value of
6.02mgml- and was the least effective of the drugs
examined.
Our results demonstrate that 4-S-cysteinylcatechol, a
sulphur homologue of L-dopa, is a remarkably potent agent
in killing human melanoma cells as compared with L-dopa
itself. The enhanced toxicity of 4-S-CC to melanoma cells
may be related to the presence of a sulphur atom in the
molecule, the only difference between 4-S-CC and L-dopa in
chemical structure (Figure 1). Ito et al. (1987) have indicated
that 4-S-CC is a much better substrate for tyrosinase than L-
dopa, suggesting that this may be due to the electron
donating resonance effect of the sulphur atom. L-dopa and
its analogues have been shown to be selectively cytotoxic to
melanoma cells (Wick et al., 1977; Wick, 1978), and its
mechanism has been postulated to be tyrosinase-mediated
oxidation of these compounds to o-quinone forms that
inhibit the activity of DNA polymerase a (Graham et al.,
1978; Wick, 1980). Thus, .the enhanced toxicity of 4-S-CC
may be ascribed to a significantly increased affinity for
tyrosinase. In addition, the sulphur atom may also increase
the incorporation of these compounds into cells by virtue of
its lipophilicity (Ito et al., 1981).
2-S-Cysteinylhydroquinone was next to 4-S-CC in killing
melanoma cells. Hydroquinone itself has been shown to have
melanocytolytic activity against melanocytes in vivo (Jimbow
et al., 1974), and Chavin et al. (1980) showed that
hydroquinone significantly prolongs the survival of
melanoma-bearing mice. Recently, Penney et al. (1984)
suggested that the cytotoxicity of hydroquinone to
melanoma cells may be via its oxidation by tyrosinase. Thus,
the potent killing activity of 2-S-CH may also be related to
the tyrosinase-mediated oxidation of the hydroquinone
moiety.
3-S-Cysteinyl-5-methylcatechol had an intermediate
activity in killing melanoma cells among the drugs examined.
Since Fujita et al. (1980) have demonstrated the 5-S-
cysteinyldopa, an intermediate in the pathway from L-dopa
to pheomelanin, is much more cytotoxic to melanoma cells
than L-dopa, the enhanced effect of 3-S-C-5-MC may be
related to the fact that its chemical structure is closely
analogous to that of 5-S-cysteinyldopa (Figure 1).
Our results indicate that 4-S-CC and its analogues possess
remarkably potent killing activities to human melanoma
cells, and that these effects are closely related to their
chemical structure. L-dopa was found to have only a weak
killing effect, though it has been reported that L-dopa
inhibits selectively the growth of melanoma cells (Wick et al.,
1977). Thus, 4-S-CC and analogues may make a new,
effective cytotoxic agent for the rational chemotherapy that
can ameliorate malignant melanoma.
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